Global University Venturing

Repare Therapeutics, which is commericalising precision cancer drugs based on research at UofT and NYU, added $33m to its IPO after its shares rose 65% post-offering.

Cambridge Innovation Capital has released its annual results, celebrating a 46% increase in net asset value and its first IPO exit.

University of Washington’s artificial intelligence-powered customer support spinout AnswerDash has been bought by CloudEngage.

Receipt Bank has purchased Xavier Analytics, a portfolio company of SETsquared Bristol.

MemorialCare Innovation Fund contributed to a series D round that brought the Caltech spinout's overall funding to more than $36m.

Smart forklift developer VisionNav has now collected more than $18m altogether to advance work from Chinese University of Hong Kong and University of Tokyo.

Hartford Healthcare returned for a $50m series C round that will support the Stanford spinout in advancing potential treatments for severe liver and inflammatory bowel diseases.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Main Sequence Ventures has returned for a $10m series B round that will drive Kasada's expansion efforts following its opening of headquarters in the US.

Ona Therapeutics is working on treatments for metastatic cancer and has collected series A funding from investors including Bpifrance.

Material Impact has participated in a series C1 round for Zero Mass Water, the ASU spinout that has created a system to convert air and sunlight to drinking water.